Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.45 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.45 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.45 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 2/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL9708933 | 0.95 | LOXL2 (0.59) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL1852998 | 0.95 | CA12 (0.60) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL27707392 | 0.86 | LOXL2 (0.57) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL15646205 | 0.86 | CA1 (0.50) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL16594355 | 0.86 | CA12 (0.50) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL7708759 | 0.85 | KMT2A (0.52) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL7588248 | 0.85 | ALDH1A1 (0.55) | LOXL2CA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL5963878 | 0.84 | CA12 (0.49) | LOXL2CA12CA1CA2CA9 | |
| Hydrazine SCHEMBL10771056 | 0.84 | CA12 (0.62) | LOXL2CA12CA1CA2CA9 | |
| SCHEMBL109451 | 0.84 | CA1 (0.61) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109060733-B | Iron ion molecular fluorescent sensor and preparation method thereof | 苏州首通科技发展有限公司 | 2019-11-05 | — | — | CN | claimed |
| CN-108864046-B | Fe2+Molecular fluorescence test solution, preparation method and application thereof | 苏州首通科技发展有限公司 | 2019-11-05 | — | — | CN | claimed |
| CN-108587605-B | Fe3+Molecular fluorescent compound and preparation method thereof | 中国科学院生物物理研究所 | 2019-08-02 | — | — | CN | claimed |
| CN-108801992-B | Fe3+Molecular fluorescence sensor and preparation method thereof | 中国科学院生物物理研究所 | 2019-08-02 | — | — | CN | claimed |
| CN-108675989-B | Fe3+Molecular fluorescence test agent and preparation method thereof | 中国科学院生物物理研究所 | 2019-07-02 | — | — | CN | claimed |
| CN-109060733-A | Iron ion molecular fluorescent sensor and preparation method thereof | 苏州首通科技发展有限公司 | 2018-12-21 | — | — | CN | claimed |
| CN-108929285-A | The preparation method of Na+ molecular fluorescence intermediate and Na+ molecular fluorescence sensor | 苏州首通科技发展有限公司 | 2018-12-04 | — | — | CN | claimed |
| CN-108864046-A | Fe2+Molecular fluorescence test solution, preparation method and application thereof | 苏州首通科技发展有限公司 | 2018-11-23 | — | — | CN | claimed |
| CN-108801992-A | Fe3+Molecular fluorescence sensor and preparation method thereof | 中国科学院生物物理研究所 | 2018-11-13 | — | — | CN | claimed |
| CN-108675989-A | Fe3+Molecular fluorescence test agent and preparation method thereof | 中国科学院生物物理研究所 | 2018-10-19 | — | — | CN | claimed |
| CN-108587605-A | Fe3+Molecular fluorescent compound and preparation method thereof | 中国科学院生物物理研究所 | 2018-09-28 | — | — | CN | claimed |
| EP-4719602-A1 | ANTI-HIV COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20250333395-A1 | BENZYLAMIDE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA RECEPTOR I/ALK5 | Agomab Spain, S.L.U. (ES) | 2025-10-30 | — | — | US | disclosed |
| US-12297186-B2 | Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5 | Agomab Spain, S.L.U. (ES) | 2025-05-13 | — | — | US | disclosed |
| US-12246000-B2 | Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides | VILNIUS UNIVERSITY (LT) | 2025-03-11 | — | — | US | disclosed |
| US-4699904-A | ANTIINFLAMMATORY AND ANTIDEGENERATIVE AGENTS | MERCK & CO., INC. (US) | 1987-10-13 | — | — | US | disclosed |
| EP-0236734-A2 | 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups | CIBA-GEIGY AG (CH) | 1987-09-16 | — | — | EP | disclosed |
| EP-0207447-A2 | Tetrazolyl derivatives of beta-lactams useful as elastase inhibitors | MERCK & CO. INC. (US) | 1987-01-07 | — | — | EP | disclosed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | disclosed |
| EP-0143746-A2 | 5-Amino 4-hydroxy-valeryl-substituted derivatives | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12297186-B2 | Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5 | TGFBR2, TGFBR1, ACVR1 | LOXL2 201/4885CA12 3476/4885CA1 4684/4885 |
| US-20250333395-A1 | BENZYLAMIDE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR-BETA RECEPTOR I/ALK5 | TGFBR2, TGFBR1, ACVR1 | LOXL2 201/4885CA12 3476/4885CA1 4684/4885 |
| US-12246000-B2 | Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides | APP, APBA1, IAPP | LOXL2 4669/4885CA12 3715/4885CA1 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.